| ANOVA | analysis of variance |
| ARIC | Atherosclerosis Risk in Communities |
| BMI | body mass index |
| CKD | chronic kidney disease |
| CPMG | Carr-Purcell-Meiboom-Gill |
| CV-ANOVA | analysis of variance of cross-validated residuals |
| CVD | cardiovascular disease |
| DALY | disability-adjusted life year |
| FDR | false discovery rate |
| HMDB | Human Metabolome Database |
| HSD | Honest Significant Difference |
| KEGG | Kyoto Encyclopaedia of Genes and Genomes |
| MANS | Malaysian Adult Nutrition Survey |
| MLS | Malaysia Lipid Study |
| MVDA | multivariate data analysis |
| NCD | non-communicable disease |
| NHMS | National Health and Morbidity Survey |
| NMR | nuclear magnetic resonance |
| OPLS-DA | orthogonal partial least squares-discriminant analysis |
| PCA | principal component analysis |
| PLS-DA | partial least squares-discriminant analysis |
| PURE | Prospective Urban Rural Epidemiology |
| SSB | sugar-sweetened beverage |
| T2DM | type 2 diabetes mellitus |
| TCA | tricarboxylic acid |
| TSP | 3-(Trimethylsilyl) propionic-2,2,3,3-d4 |
| VIP | variable importance in projection |
| ZDF | Zucker Diabetic Fatty |
| Zlean | lean Zucker |